Stablon Articles
Stablon - keeps you calm without being drowsy
Stablon - Address anxiety and depression without feeling sedated.

Stablon keeps you calm without
being drowsy

Stablon is a novel serotonin enhancer that produces fewer side effects than common anti-depressants

Stablon is used as an anti-depressant. It improves the availability of the calming neurotransmitter serotonin. But rather than blocking the uptake of serotonin in the manner of other anti-depressants like Prozac® or Paxil®, Stablon actually increases the uptake of serotonin.

It, as yet, has not been clearly defined precisely why Stablon produces the same effect as these SSRI anti-depressants, whilst apparently acting in the opposite way. But Stablon has attracted the interest of physicians because of one important difference from the common, widely used anti-depressants – certain side-effects are not present when Stablon is used. In particular, Stablon is not known to interfere with the libido/sexual appetite and does not result in drowsiness in the majority of cases.

Dosages:
Typical dosages are 12.5mg two or three times daily.

Caution:
Like most anti-depressants, Stablon could interfere with other anti-depressants, particularly MAO inhibitors (including Gerovital-H3) and other SSRIs such as Prozac®. Therefore, if you intend to combine Stablon with any other anti-depressants, you must only do so under the guidance of a physician.

Stablon - Address anxiety and depression without feeling sedated.

Stablon (chemical name, Tianeptine) was first manufactured in the early 1980s by French researchers Antoine Deslandes and Michael Spedding. Stablon is what is referred to as a selective serotonin re-uptake enhancer (SSRE). It is commonly prescribed as an anti-depressant/anti-anxiety medication, as it improves the availability and uptake of serotonin. It is thought to reverse neuronal damage caused by persistent, uncontrolled stress, and is non-sedating.

While Stablon is believed to have strong anti-depressant properties, fewer side effects have been noted than with the more commonly prescribed anti-depressants. It differs in the way it is metabolized by the body, and as such, there is less likelihood of drug to drug interactions.

Accordingly, it has been suggested that it may be particularly suitable for elderly patients and for those suffering alcohol withdrawal, as these patients tend to be more sensitive to the effects of psychotropic drugs. It is also used for treating major depression and depressed bipolar disorder. Stablon is not known to interfere with the libido and, as is common with other anti-depressant medications, it does not normally impair cognitive function.

Other Benefits

Research now suggests that Stablon is very effective for treating asthma. In 1998, Dr. Fuad Lechin and colleagues from the Central University of Venezuela Institute of Experimental Medicine, published the results of a year long randomized controlled trial involving asthmatic children.

The study confirmed that those children who received Stablon experienced a dramatic decline in clinical rating, and improved lung function. Furthermore, a study undertaken in 2005 illustrated that Stablon was effective in treating men with depression and erectile dysfunction.

More recent research is being undertaken in treating Attention Defecit (Hyperactive) Disorder (ADD/ADHD), and a new clinical trial is underway for treating fibromyalgia.